Literature DB >> 20473522

Age-dependent changes in peripheral blood dendritic cell subsets in normal children and children with specific polysaccharide antibody deficiency (SPAD).

Harumi Jyonouchi1, Chongwei Cui, Lee Geng, Zhiwei Yin, Patricia Fitzgerald-Bocarsly.   

Abstract

Myeloid and plasmacytoid dendritic cells (MDC/PDC) play crucial roles in bridging adaptive and innate immunity by affecting development of both cellular and humoral immunity. The immune system evolves after birth as reflected in dynamic changes in numbers and functions of various immune cells with age. However, age-associated changes in DC subsets in children have not been elucidated despite the fact that such normative data are crucial for evaluating alternations of DC subsets in various pediatric diseases. This study addressed age-associated changes in DC subsets and CD40/86 expression on PDC (markers of maturation/activation) in 50 healthy children in comparison with 25 children with specific polysaccharide antibody deficiency (SPAD). Our results revealed age-dependent decrease of PDC numbers (p < 0.0001), although there was no age-associated changes in CD40/CD86 expression. MDC1/MDC2 numbers did not reveal such linear age-dependent changes and MDC1/PDC ratio reached around 2 as typically seen in young adults after 10 years of age. In contrast, SPAD patients did not reveal such age-associated changes and showed decreased fluorescence intensity of CD86 in PDC cells. These results indicate lineage specific, age-dependent changes in DC subsets in normal children and possible altered development of these cells in SPAD children, emphasizing the importance of age-appropriate controls.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20473522      PMCID: PMC3579493          DOI: 10.1007/s00431-010-1210-y

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  37 in total

1.  BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood.

Authors:  A Dzionek; A Fuchs; P Schmidt; S Cremer; M Zysk; S Miltenyi; D W Buck; J Schmitz
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

Review 2.  Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses.

Authors:  Ian MacLennan; Carola Vinuesa
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

3.  DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL.

Authors:  Mikhail B Litinskiy; Bernardetta Nardelli; David M Hilbert; Bing He; Andras Schaffer; Paolo Casali; Andrea Cerutti
Journal:  Nat Immunol       Date:  2002-08-05       Impact factor: 25.606

Review 4.  The who, how and where of antigen presentation to B cells.

Authors:  Facundo D Batista; Naomi E Harwood
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

5.  Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors.

Authors:  S Feldman; D Stein; S Amrute; T Denny; Z Garcia; P Kloser; Y Sun; N Megjugorac; P Fitzgerald-Bocarsly
Journal:  Clin Immunol       Date:  2001-11       Impact factor: 3.969

6.  Interferon-alpha generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infection.

Authors:  F P Siegal; P Fitzgerald-Bocarsly; B K Holland; M Shodell
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

7.  Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease.

Authors:  Klaus Warnatz; Axel Denz; Ruth Dräger; Moritz Braun; Christoph Groth; Guido Wolff-Vorbeck; Hermann Eibel; Michael Schlesier; Hans Hartmut Peter
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

8.  Age-related changes in human blood dendritic cell subpopulations.

Authors:  N Teig; D Moses; S Gieseler; U Schauer
Journal:  Scand J Immunol       Date:  2002-05       Impact factor: 3.487

9.  Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy.

Authors:  Xiomara Usuga; Carlos Julio Montoya; Alan L Landay; Maria Teresa Rugeles
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-01       Impact factor: 3.731

10.  Plasmacytoid dendritic cells during infancy are inversely associated with childhood respiratory tract infections and wheezing.

Authors:  John W Upham; Guicheng Zhang; Angela Rate; Stephanie T Yerkovich; Merci Kusel; Peter D Sly; Patrick G Holt
Journal:  J Allergy Clin Immunol       Date:  2009-09-06       Impact factor: 10.793

View more
  5 in total

1.  A correlation of measles specific antibodies and the number of plasmacytoid dendritic cells is observed after measles vaccination in 9 month old infants.

Authors:  Miguel L García-León; Laura C Bonifaz; Bogart Espinosa-Torres; Brenda Hernández-Pérez; Lino Cardiel-Marmolejo; José I Santos-Preciado; Rosa M Wong-Chew
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Differential response of BDCA-1+ and BDCA-3+ myeloid dendritic cells to respiratory syncytial virus infection.

Authors:  Meera R Gupta; Deepthi Kolli; Roberto P Garofalo
Journal:  Respir Res       Date:  2013-07-05

Review 3.  Postnatal Innate Immune Development: From Birth to Adulthood.

Authors:  Anastasia Georgountzou; Nikolaos G Papadopoulos
Journal:  Front Immunol       Date:  2017-08-11       Impact factor: 7.561

4.  Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells.

Authors:  Meera R Gupta; Deepthi Kolli; Claudio Molteni; Antonella Casola; Roberto P Garofalo
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

5.  Age-related alterations in blood and colonic dendritic cell properties.

Authors:  Rakesh Vora; David Bernardo; Lydia Durant; Durga Reddi; Ailsa L Hart; John M E Fell; Hafid O Al-Hassi; Stella C Knight
Journal:  Oncotarget       Date:  2016-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.